Gastric bypass can have a strong metabolic effect and may be considered for patients with type 2 diabetes, but the best option depends on the patients full medical history and should be discussed with a bariatric surgeon
Treatments like SGLT2i and GLP-1 RA are recommended as part of a comprehensive approach to reduce cardiorenal outcome risk, often in addition to established treatments like RAASi in patients with type 2 diabetes
Adv Healthc Mater 11(20):e2201140
By 48 weeks, these figures increased to 8.7%, 17.1%, 22.8%, and 24.2%, respectively, versus 2.1% for placebo
Discrimination index The preference for and therefore recognition of the novel object, the novel arm in the Y maze, or the mouse over the empty cage were assessed by calculating the discrimination index (Ennaceur & Delacour, 1988): The discrimination indices of all genotype and treatment groups were compared individually with a theoretical value of 0, which would indicate no preference for the novel or familiar object, Y maze arm, or cage with mouse over empty cage using a one-sample t test
Eligibility is determined through medical evaluation